1 |
Biotin
| 1件: Biotin Biotin | 4件: BIOTIN BIOTIN; Biotina; D-BIOTIN; Vitamin B7; | - | - | 5件: 2 2, 8, 10, 13, 20 |
2 |
Benzoic acid
| 1件: Benzoic acid Benzoic acid | 1件: Benzoic acid Benzoic acid; | - | - | 1件: 51 51 |
3 |
Benzyl alcohol
| - | 0件: | - | - | - |
4 |
Bacitracin
| - | 0件: | - | - | - |
5 |
Baclofen
| 1件: Baclofen Baclofen | 2件: BACLOFEN BACLOFEN; Kemstro; | 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 |
6 |
Benzonatate
| - | 0件: | - | - | - |
7 |
Benzquinamide
| - | 0件: | - | - | - |
8 |
Betamethasone
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
9 |
Bisacodyl
| 1件: Bisacodyl Bisacodyl | 1件: Bisacodyl Bisacodyl; | - | - | 1件: 13 13 |
10 |
Budesonide
| 1件: Budesonide Budesonide | 4件: BUDESONIDE BUDESONIDE; Entocort; Jorveza; Symbicort; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
11 |
Bumetanide
| 1件: Bumetanide Bumetanide | 1件: Bumetanide Bumetanide; | 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 158 |
12 |
Busulfan
| 1件: Busulfan Busulfan | 3件: Busilvex Busilvex; Busulfan; BUSULFANO; | - | - | 13件: 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
13 |
Benzocaine
| - | 0件: | - | - | - |
14 |
Buformin
| - | 0件: | - | - | - |
15 |
Betaxolol hydrochloride
| - | 0件: | - | - | - |
16 |
Benazepril hydrochloride
| 1件: Benazepril Benazepril | 1件: Benazepril Benazepril; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 49 49, 57, 218, 224 |
17 |
Bepridil hydrochloride
| - | 0件: | - | - | - |
18 |
Bisoprolol fumarate
| 1件: Bisoprolol Bisoprolol | 2件: Bisoprolol Bisoprolol; Bisoprolol Fumarate; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 67 67, 86, 113 |
19 |
Bretylium tosylate
| - | 0件: | - | - | - |
20 |
Bendroflumethiazide
| 1件: Bendroflumethiazide Bendroflumethiazide | 1件: BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; | 1件: SLC12A3 SLC12A3 💬 | - | 1件: 67 67 |
21 |
Benzthiazide
| - | 0件: | - | - | - |
22 |
Brinzolamide
| - | 0件: | - | - | - |
23 |
Brompheniramine maleate
| - | 0件: | - | - | - |
24 |
Bitolterol mesylate
| - | 0件: | - | - | - |
25 |
Beclomethasone dipropionate
| 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: BECLOMETASONE DIPROPIONATE BECLOMETASONE DIPROPIONATE; Beclomethasone dipropionate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 85 85, 97, 98 |
26 |
Buspirone hydrochloride
| 1件: Buspirone Buspirone | 2件: Buspirone Buspirone; Buspirone Hydrochloride; | 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 |
27 |
Bismuth subsalicylate
| - | 0件: | - | - | - |
28 |
Butamben
| - | 0件: | - | - | - |
29 |
Benztropine mesylate
| - | 0件: | - | - | - |
30 |
Biperiden
| - | 0件: | - | - | - |
31 |
Bromocriptine mesylate
| 1件: Bromocriptine Bromocriptine | 1件: BROMOCRIPTINE BROMOCRIPTINE; | 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 74 |
32 |
Botulinum toxin type A
| 1件: Botulinum toxin type A Botulinum toxin type A | 8件: Botox Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; | 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 13件: 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
33 |
Bithionol
| - | 0件: | - | - | - |
34 |
Bupropion hydrochloride
| 1件: Bupropion Bupropion | 2件: Bupropion Bupropion; Bupropion Hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
35 |
Buprenorphine hydrochloride
| 1件: Buprenorphine Buprenorphine | 1件: Buprenorphine Buprenorphine; | 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 298 |
36 |
Butorphanol tartrate
| - | 0件: | - | - | - |
37 |
Butoconazole nitrate
| - | 0件: | - | - | - |
38 |
Bicalutamide
| - | 0件: | - | - | - |
39 |
Betamethasone sodium phosphate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
40 |
Bethanechol chloride
| 1件: Bethanechol Bethanechol | 1件: Bethanechol Bethanechol; | 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 98 98 |
41 |
Benzbromarone
| 1件: Benzbromarone Benzbromarone | 1件: BENZBROMARONE BENZBROMARONE; | 1件: SLC22A12 SLC22A12 💬 | - | 1件: 86 86 |
42 |
Biapenem
| - | 0件: | - | - | - |
43 |
Boric acid
| - | 0件: | - | - | - |
44 |
Butenafine hydrochloride
| - | 0件: | - | - | - |
45 |
Bromperidol
| - | 0件: | - | - | - |
46 |
Bucetin
| - | 0件: | - | - | - |
47 |
Benzyl benzoate
| - | 0件: | - | - | - |
48 |
Blonanserin
| - | 0件: | - | - | - |
49 |
Betazole hydrochloride
| - | 0件: | - | - | - |
50 |
Bisoxatin acetate
| - | 0件: | - | - | - |
51 |
Bosentan
| 1件: Bosentan Bosentan | 2件: Bosentan Bosentan; Tracleer; | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
52 |
Bromazepam
| - | 0件: | - | - | - |
53 |
Benfotiamine
| - | 0件: | - | - | - |
54 |
Bufexamac
| - | 0件: | - | - | - |
55 |
Bisibuthiamine
| - | 0件: | - | - | - |
56 |
Bentiromide
| 1件: Bentiromide Bentiromide | 0件: | - | - | 6件: 51 51, 89, 113, 117, 298, 299 |
57 |
Betamethasone valerate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
58 |
Bezafibrate
| 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate Bezafibrate; | 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
59 |
Bromovalerylurea
| - | 0件: | - | - | - |
60 |
Bismuth subgallate
| - | 0件: | - | - | - |
61 |
Betamethasone acetate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
62 |
Benzyl nicotinate
| - | 0件: | - | - | - |
63 |
Butyl parahydroxybenzoate
| - | 0件: | - | - | - |
64 |
Bupivacaine hydrochloride
| 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine Bupivacaine; BUPIVACAINE HYDROCHLORIDE; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 8件: 46 46, 51, 53, 70, 96, 168, 226, 298 |
65 |
Bronopol
| - | 0件: | - | - | - |
66 |
Bendazac
| - | 0件: | - | - | - |
67 |
Bethanidine sulfate
| - | 0件: | - | - | - |
68 |
Betamethasone dipropionate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
69 |
Bismuth subnitrate
| - | 0件: | - | - | - |
70 |
Bepotastine besylate
| - | 0件: | - | - | - |
71 |
Bropirimine
| - | 0件: | - | - | - |
72 |
beta-Butoxyethyl nicotinate
| - | 0件: | - | - | - |
73 |
Barbital
| - | 0件: | - | - | - |
74 |
Brotizolam
| - | 0件: | - | - | - |
75 |
Bismuth subcarbonate
| - | 0件: | - | - | - |
76 |
Broxuridine
| - | 0件: | - | - | - |
77 |
Benoxinate hydrochloride
| 1件: Oxybuprocaine Oxybuprocaine | 1件: Oxybuprocaine Oxybuprocaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
78 |
Bifonazole
| - | 0件: | - | - | - |
79 |
Bucillamine
| 1件: Bucillamine Bucillamine | 1件: Bucillamine Bucillamine; | - | - | 1件: 46 46 |
80 |
Benziodarone
| - | 0件: | - | - | - |
81 |
Bemegride
| - | 0件: | - | - | - |
82 |
Betamethasone butyrate propionate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
83 |
Barium sulfate
| - | 0件: | - | - | - |
84 |
Brimonidine tartrate
| 1件: Brimonidine Brimonidine | 2件: Brimonidine Brimonidine; Brimonidine Tartrate; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 90 |
85 |
Buclizine hydrochloride
| - | 0件: | - | - | - |
86 |
Bleomycin sulfate
| 1件: Bleomycin Bleomycin | 1件: Bleomycin Bleomycin; | - | - | 4件: 96 96, 278, 279, 280 |
87 |
Biperiden hydrochloride
| - | 0件: | - | - | - |
88 |
Biperiden lactate
| - | 0件: | - | - | - |
89 |
Betamethasone benzoate
| 1件: Betamethasone Betamethasone | 1件: Betamethasone Betamethasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
90 |
Benzylpenicillin
| 1件: Benzylpenicillin Benzylpenicillin | 0件: | - | - | 1件: 46 46 |
91 |
Bisoprolol
| 1件: Bisoprolol Bisoprolol | 2件: Bisoprolol Bisoprolol; Bisoprolol Fumarate; | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 67 67, 86, 113 |
92 |
Betadex
| 1件: Betadex Betadex | 1件: Beta-cyclodextrin Beta-cyclodextrin; | - | - | 1件: 19 19 |
93 |
Benznidazole
| 1件: Benznidazole Benznidazole | 1件: Benznidazole Benznidazole; | - | - | 1件: 65 65 |
94 |
Brofaromine
| - | 0件: | - | - | - |
95 |
Butobarbital
| - | 0件: | - | - | - |
96 |
Benperidol
| - | 0件: | - | - | - |
97 |
Butaperazine
| - | 0件: | - | - | - |
98 |
Balsalazide disodium
| 1件: Balsalazide Balsalazide | 3件: 2-Hydroxybenzoic acid 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium; | - | - | 1件: 97 97 |
99 |
Beraprost
| 1件: Beraprost Beraprost | 1件: Beraprost Beraprost; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
100 |
Bimatoprost
| - | 0件: | - | - | - |
101 |
Bacitracin methylenedisalicylate
| - | 0件: | - | - | - |
102 |
Bacitracin zinc
| - | 0件: | - | - | - |
103 |
Bambermycins
| - | 0件: | - | - | - |
104 |
Basifungin
| - | 0件: | - | - | - |
105 |
Basiliximab
| 1件: Basiliximab Basiliximab | 2件: Basiliximab Basiliximab; Simulect; | 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 6件: 2 2, 50, 66, 97, 222, 228 |
106 |
Batimastat
| - | 0件: | - | - | - |
107 |
BCG vaccine
| 1件: BCG vaccine BCG vaccine | 0件: | - | - | 1件: 299 299 |
108 |
Becaplermin
| - | 0件: | - | - | - |
109 |
Bectumomab
| - | 0件: | - | - | - |
110 |
Belimumab
| 1件: Belimumab Belimumab | 2件: BELIMUMAB BELIMUMAB; BENLYSTA; | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 12件: 11 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300 |
111 |
Belladonna
| - | 0件: | - | - | - |
112 |
Benazeprilat
| - | 0件: | - | - | - |
113 |
Benoxaprofen
| - | 0件: | - | - | - |
114 |
Benserazide
| 1件: Benserazide Benserazide | 1件: BENSERAZIDE BENSERAZIDE; | 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
115 |
Bentazepam
| - | 0件: | - | - | - |
116 |
Bentonite
| - | 0件: | - | - | - |
117 |
Bentoquatam
| - | 0件: | - | - | - |
118 |
Benzoin
| - | 0件: | - | - | - |
119 |
Benzoyl peroxide
| - | 0件: | - | - | - |
120 |
Benzylpenicilloyl polylysine
| - | 0件: | - | - | - |
121 |
Beractant
| - | 0件: | - | - | - |
122 |
beta Carotene
| 1件: Beta carotene Beta carotene | 3件: Beta carotene Beta carotene; Beta-Carotene; BETACAROTENE; | - | - | 2件: 13 13, 96 |
123 |
Betiatide
| - | 0件: | - | - | - |
124 |
Bexarotene
| 1件: Bexarotene Bexarotene | 2件: Bexarotene Bexarotene; Targretin; | 3件: RXRA RXRA, RXRB, RXRG 💬 | 17件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 13 13, 75 |
125 |
Bindarit
| - | 0件: | - | - | - |
126 |
Binetrakin
| 1件: Binetrakin Binetrakin | 1件: Interleukin 4 Interleukin 4; | 1件: IL4 IL4 💬 | 16件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Leishmaniasis, PI3K-Akt signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 46 46 |
127 |
Binodenoson
| - | 0件: | - | - | - |
128 |
Bivalirudin
| - | 0件: | - | - | - |
129 |
Bizelesin
| - | 0件: | - | - | - |
130 |
Bolasterone
| - | 0件: | - | - | - |
131 |
Boldenone undecylenate
| - | 0件: | - | - | - |
132 |
Bortezomib
| 1件: Bortezomib Bortezomib | 3件: Bortezomib Bortezomib; Bortezomib Accord; Velcade; | 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
133 |
Brinolase
| - | 0件: | - | - | - |
134 |
Bromelains
| - | 0件: | - | - | - |
135 |
Bromfenac sodium
| - | 0件: | - | - | - |
136 |
Bromocriptine
| 1件: Bromocriptine Bromocriptine | 1件: Bromocriptine Bromocriptine; | 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 74 |
137 |
Bromodiphenhydramine hydrochloride
| - | 0件: | - | - | - |
138 |
Buquinolate
| - | 0件: | - | - | - |
139 |
Butabarbital
| - | 0件: | - | - | - |
140 |
Butalbital
| - | 0件: | - | - | - |
141 |
Buthiazide
| - | 0件: | - | - | - |
142 |
Butonate
| - | 0件: | - | - | - |
143 |
Butorphanol
| - | 0件: | - | - | - |
144 |
Butyl alcohol
| - | 0件: | - | - | - |
145 |
Becatecarin
| - | 0件: | - | - | - |
146 |
Belatacept
| 1件: Belatacept Belatacept | 2件: Belatacept Belatacept; Nulojix; | 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
147 |
Bemotrizinol
| - | 0件: | - | - | - |
148 |
Bleomycin hydrochloride
| 1件: Bleomycin Bleomycin | 1件: Bleomycin Bleomycin; | - | - | 4件: 96 96, 278, 279, 280 |
149 |
Bisoctrizole
| - | 0件: | - | - | - |
150 |
Bosutinib
| 1件: Bosutinib Bosutinib | 1件: BOSUTINIB BOSUTINIB; | 2件: ABL1 ABL1, SRC 💬 | 49件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 2 2, 67 |
151 |
Brecanavir
| - | 0件: | - | - | - |
152 |
Batroxobin
| - | 0件: | - | - | - |
153 |
Bevacizumab
| 1件: Bevacizumab Bevacizumab | 2件: AVASTIN AVASTIN; Bevacizumab; | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 9件: 13 13, 34, 85, 86, 87, 89, 227, 280, 331 |
154 |
Batabulin
| - | 0件: | - | - | - |
155 |
Bavituximab
| - | 0件: | - | - | - |
156 |
Bifeprunox
| - | 0件: | - | - | - |
157 |
Bremelanotide
| - | 0件: | - | - | - |
158 |
Bromopride
| - | 0件: | - | - | - |
159 |
Broxyquinoline
| - | 0件: | - | - | - |
160 |
Buprenorphine
| 1件: Buprenorphine Buprenorphine | 1件: Buprenorphine Buprenorphine; | 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 298 |
161 |
Bietaserpine
| - | 0件: | - | - | - |
162 |
Buflomedil
| - | 0件: | - | - | - |
163 |
Butalamine
| - | 0件: | - | - | - |
164 |
Benfluorex
| - | 0件: | - | - | - |
165 |
Bamipine
| - | 0件: | - | - | - |
166 |
Brodimoprim
| - | 0件: | - | - | - |
167 |
Brivudine
| - | 0件: | - | - | - |
168 |
Buserelin
| - | 0件: | - | - | - |
169 |
Bumadizone
| - | 0件: | - | - | - |
170 |
Butanilicaine
| - | 0件: | - | - | - |
171 |
Bezitramide
| - | 0件: | - | - | - |
172 |
Benorilate
| - | 0件: | - | - | - |
173 |
Barbexaclone
| - | 0件: | - | - | - |
174 |
Beclamide
| - | 0件: | - | - | - |
175 |
Bornaprine
| - | 0件: | - | - | - |
176 |
Budipine
| - | 0件: | - | - | - |
177 |
Bambuterol
| - | 0件: | - | - | - |
178 |
Bibrocathol
| - | 0件: | - | - | - |
179 |
Bunaftine
| - | 0件: | - | - | - |
180 |
Bacampicillin
| - | 0件: | - | - | - |
181 |
Balsalazide
| 1件: Balsalazide Balsalazide | 3件: 2-Hydroxybenzoic acid 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium; | - | - | 1件: 97 97 |
182 |
Bambuterol hydrochloride
| - | 0件: | - | - | - |
183 |
Bamethan
| - | 0件: | - | - | - |
184 |
Bamifylline
| - | 0件: | - | - | - |
185 |
Barnidipine
| - | 0件: | - | - | - |
186 |
Beclometasone
| 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: Beclometasone dipropionate Beclometasone dipropionate; Beclomethasone dipropionate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 85 85, 97, 98 |
187 |
Befunolol
| - | 0件: | - | - | - |
188 |
Bekanamycin
| 1件: Kanamycin Kanamycin | 1件: Kanamycin Kanamycin; | - | - | 2件: 96 96, 291 |
189 |
Benactyzine
| - | 0件: | - | - | - |
190 |
Benazepril
| 1件: Benazepril Benazepril | 1件: Benazepril Benazepril; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 49 49, 57, 218, 224 |
191 |
Bencyclane
| - | 0件: | - | - | - |
192 |
Bendamustine
| 1件: Bendamustine Bendamustine | 2件: Bendamustine Bendamustine; BENDAMUSTINE HYDROCHLORIDE; | - | - | 2件: 28 28, 61 |
193 |
Benidipine
| - | 0件: | - | - | - |
194 |
Benzatropine
| - | 0件: | - | - | - |
195 |
Benproperine
| - | 0件: | - | - | - |
196 |
Benzfetamine
| - | 0件: | - | - | - |
197 |
Benzydamine
| - | 0件: | - | - | - |
198 |
Benzyl hydroxybenzoate
| - | 0件: | - | - | - |
199 |
Benzylthiouracil
| - | 0件: | - | - | - |
200 |
Bepridil
| - | 0件: | - | - | - |
201 |
Bergaptene
| - | 0件: | - | - | - |
202 |
Betahistine
| - | 0件: | - | - | - |
203 |
Betaine
| 1件: Betaine Betaine | 1件: Betaine Betaine; | - | - | 2件: 201 201, 337 |
204 |
Betaxolol
| - | 0件: | - | - | - |
205 |
Bifemelane
| - | 0件: | - | - | - |
206 |
Bioallethrin
| - | 0件: | - | - | - |
207 |
Bisoxatin
| - | 0件: | - | - | - |
208 |
Bitolterol
| - | 0件: | - | - | - |
209 |
Bleomycin
| 1件: Bleomycin Bleomycin | 1件: Bleomycin Bleomycin; | - | - | 4件: 96 96, 278, 279, 280 |
210 |
Boldenone
| - | 0件: | - | - | - |
211 |
Bopindolol
| - | 0件: | - | - | - |
212 |
Bosentan
| 1件: Bosentan Bosentan | 2件: Bosentan Bosentan; Tracleer; | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
213 |
Brimonidine
| 1件: Brimonidine Brimonidine | 2件: Brimonidine Brimonidine; Brimonidine tartrate; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 90 |
214 |
Bromfenac
| - | 0件: | - | - | - |
215 |
Bromhexine
| - | 0件: | - | - | - |
216 |
Brompheniramine
| - | 0件: | - | - | - |
217 |
Brovanexine
| - | 0件: | - | - | - |
218 |
Bucladesine
| 1件: Bucladesine Bucladesine | 1件: Bucladesine Bucladesine; | 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 246 246 |
219 |
Buclizine
| - | 0件: | - | - | - |
220 |
Bunazosin
| - | 0件: | - | - | - |
221 |
Bupivacaine
| 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine Bupivacaine; BUPIVACAINE HYDROCHLORIDE; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 8件: 46 46, 51, 53, 70, 96, 168, 226, 298 |
222 |
beta-Alanine
| 1件: beta-Alanine beta-Alanine | 1件: Beta-Alanine Beta-Alanine; | - | - | 1件: 13 13 |
223 |
Bupranolol
| - | 0件: | - | - | - |
224 |
Bupropion
| 1件: Bupropion Bupropion | 2件: Bupropion Bupropion; Bupropion Hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
225 |
Buspirone
| 1件: Buspirone Buspirone | 2件: Buspirone Buspirone; Buspirone Hydrochloride; | 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 |
226 |
Butamirate
| - | 0件: | - | - | - |
227 |
Butenafine
| - | 0件: | - | - | - |
228 |
Butoconazole
| - | 0件: | - | - | - |
229 |
Butriptyline
| - | 0件: | - | - | - |
230 |
Bupropion hydrobromide
| 1件: Bupropion Bupropion | 2件: Bupropion Bupropion; Bupropion Hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
231 |
beta-Sitosterol
| 1件: beta-Sitosterol beta-Sitosterol | 1件: Sitosterol Sitosterol; | - | - | 1件: 260 260 |
232 |
Baminercept
| 1件: Baminercept Baminercept | 2件: Baminercept Baminercept; Baminercept alfa; | 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 53, 97 |
233 |
Bapineuzumab
| - | 0件: | - | - | - |
234 |
Becocalcidiol
| - | 0件: | - | - | - |
235 |
Begacestat
| - | 0件: | - | - | - |
236 |
Belinostat
| - | 0件: | - | - | - |
237 |
Betrixaban
| - | 0件: | - | - | - |
238 |
Boceprevir
| - | 0件: | - | - | - |
239 |
Brivanib alaninate
| - | 0件: | - | - | - |
240 |
Brivaracetam
| 1件: Brivaracetam Brivaracetam | 1件: BRIVARACETAM BRIVARACETAM; | 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 |
241 |
Blinatumomab
| - | 0件: | - | - | - |
242 |
Bilastine
| - | 0件: | - | - | - |
243 |
Balapiravir
| - | 0件: | - | - | - |
244 |
Bardoxolone
| 1件: Bardoxolone Bardoxolone | 1件: Bardoxolone Bardoxolone; | - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
245 |
Bardoxolone methyl
| 1件: Bardoxolone methyl Bardoxolone methyl | 1件: Bardoxolone methyl Bardoxolone methyl; | - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
246 |
Bixalomer
| - | 0件: | - | - | - |
247 |
Brentuximab vedotin
| 1件: Brentuximab vedotin Brentuximab vedotin | 2件: Brentuximab Brentuximab; Brentuximab vedotin; | 10件: TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 49 49, 51 |
248 |
Briakinumab
| - | 0件: | - | - | - |
249 |
Brivanib
| - | 0件: | - | - | - |
250 |
Budiodarone
| - | 0件: | - | - | - |
251 |
Bepotastine
| - | 0件: | - | - | - |
252 |
Bismuth subcitrate potassium
| - | 0件: | - | - | - |
253 |
Bornyl acetate
| - | 0件: | - | - | - |
254 |
Bavisant
| 1件: Bavisant Bavisant | 1件: Bavisant Bavisant; | 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
255 |
Bedaquiline
| - | 0件: | - | - | - |
256 |
Benralizumab
| 1件: Benralizumab Benralizumab | 2件: Benralizumab Benralizumab; Fasenra; | 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
257 |
Brodalumab
| 1件: Brodalumab Brodalumab | 1件: Brodalumab Brodalumab; | 1件: IL17RA IL17RA 💬 | 3件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬 | 2件: 37 37, 51 |
258 |
Blosozumab
| - | 0件: | - | - | - |
259 |
Bitopertin
| - | 0件: | - | - | - |
260 |
Bafetinib
| - | 0件: | - | - | - |
261 |
Baricitinib
| 1件: Baricitinib Baricitinib | 2件: BARICITINIB BARICITINIB; Olumiant; | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 13件: 41 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325 |
262 |
Brexpiprazole
| - | 0件: | - | - | - |
263 |
Balugrastim
| - | 0件: | - | - | - |
264 |
Blisibimod
| 1件: Blisibimod Blisibimod | 1件: Blisibimod Blisibimod; | - | - | 5件: 43 43, 44, 49, 63, 66 |
265 |
Bevenopran
| - | 0件: | - | - | - |
266 |
Brilacidin
| - | 0件: | - | - | - |
267 |
Birinapant
| - | 0件: | - | - | - |
268 |
Bezlotoxumab
| 1件: Bezlotoxumab Bezlotoxumab | 1件: Bezlotoxumab Bezlotoxumab; | - | - | 2件: 96 96, 97 |
269 |
Batefenterol
| - | 0件: | - | - | - |
270 |
Brincidofovir
| - | 0件: | - | - | - |
271 |
Buparlisib
| - | 0件: | - | - | - |
272 |
Binimetinib
| 1件: Binimetinib Binimetinib | 1件: Binimetinib Binimetinib; | 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
273 |
Beclabuvir
| - | 0件: | - | - | - |
274 |
Benzhydrocodone
| - | 0件: | - | - | - |
275 |
Bradanicline
| - | 0件: | - | - | - |
276 |
Briciclib
| - | 0件: | - | - | - |
277 |
Bimagrumab
| 1件: Bimagrumab Bimagrumab | 1件: Bimagrumab Bimagrumab; | 2件: ACVR2A ACVR2A, ACVR2B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 15 15 |
278 |
Bococizumab
| - | 0件: | - | - | - |
279 |
Bempedoic acid
| - | 0件: | - | - | - |
280 |
Butylene glycol
| 1件: Butylene glycol Butylene glycol | 0件: | - | - | 2件: 28 28, 46 |
281 |
Brilliant blue G
| - | 0件: | - | - | - |
282 |
Besilesomab
| - | 0件: | - | - | - |
283 |
Basmisanil
| - | 0件: | - | - | - |
284 |
Basimglurant
| 1件: Basimglurant Basimglurant | 1件: Basimglurant Basimglurant; | - | - | 1件: 158 158 |
285 |
Bexagliflozin
| - | 0件: | - | - | - |
286 |
Brigatinib
| 1件: Brigatinib Brigatinib | 1件: Brigatinib Brigatinib; | 1件: ALK ALK 💬 | 3件: Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | 1件: 34 34 |
287 |
Bictegravir
| - | 0件: | - | - | - |
288 |
Birabresib
| - | 0件: | - | - | - |
289 |
Brazikumab
| 1件: Brazikumab Brazikumab | 1件: BRAZIKUMAB BRAZIKUMAB; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 |
290 |
Burosumab
| 1件: Burosumab Burosumab | 1件: Burosumab Burosumab; | 1件: FGF23 FGF23 💬 | 11件: Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | 1件: 238 238 |
291 |
Baloxavir marboxil
| - | 0件: | - | - | - |
292 |
Brolucizumab
| - | 0件: | - | - | - |
293 |
Berzosertib
| - | 0件: | - | - | - |
294 |
Brexanolone
| 1件: Brexanolone Brexanolone | 1件: Allopregnanolone Allopregnanolone; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 205 205 |
295 |
Biropepimut-S
| - | 0件: | - | - | - |
296 |
Brontictuzumab
| - | 0件: | - | - | - |
297 |
Balipodect
| - | 0件: | - | - | - |
298 |
Bermekimab
| 1件: Bermekimab Bermekimab | 1件: BERMEKIMAB BERMEKIMAB; | 1件: IL1A IL1A 💬 | 21件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 51 51 |
299 |
Baloxavir
| - | 0件: | - | - | - |
300 |
Brivoligide
| - | 0件: | - | - | - |
301 |
Bleselumab
| 1件: Bleselumab Bleselumab | 1件: Bleselumab Bleselumab; | 1件: CD40 CD40 💬 | 17件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | 1件: 222 222 |
302 |
Birtamimab
| 1件: Birtamimab Birtamimab | 1件: BIRTAMIMAB BIRTAMIMAB; | - | - | 1件: 28 28 |
303 |
Blarcamesine
| 1件: Blarcamesine Blarcamesine | 1件: Blarcamesine Blarcamesine; | 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬 | 14件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 |
304 |
Bemcentinib
| - | 0件: | - | - | - |
305 |
Bimiralisib
| - | 0件: | - | - | - |
306 |
Balovaptan
| - | 0件: | - | - | - |
307 |
Branebrutinib
| 1件: Branebrutinib Branebrutinib | 2件: BMS-986195 BMS-986195; Branebrutinib; | 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 3件: 46 46, 49, 53 |
308 |
Belapectin
| - | 0件: | - | - | - |
309 |
Bimekizumab
| 1件: Bimekizumab Bimekizumab | 1件: BIMEKIZUMAB BIMEKIZUMAB; | 2件: IL17A IL17A, IL17F 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 46 46, 97, 271 |
310 |
Belantamab mafodotin
| 1件: Belantamab mafodotin Belantamab mafodotin | 1件: Belantamab mafodotin Belantamab mafodotin; | 10件: TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 12件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 28 28 |
311 |
Budigalimab
| - | 0件: | - | - | - |
312 |
Bempegaldesleukin
| - | 0件: | - | - | - |
313 |
Berotralstat
| - | 0件: | - | - | - |
314 |
Bentracimab
| - | 0件: | - | - | - |
315 |
Belumosudil
| 1件: Belumosudil Belumosudil | 1件: Belumosudil Belumosudil; | 1件: ROCK2 ROCK2 💬 | 21件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
316 |
Balstilimab
| - | 0件: | - | - | - |
317 |
Bulevirtide
| - | 0件: | - | - | - |
318 |
Brexucabtagene autoleucel
| - | 0件: | - | - | - |
319 |
Bintrafusp alfa
| - | 0件: | - | - | - |
320 |
Beinaglutide
| - | 0件: | - | - | - |
321 |
Bamlanivimab
| - | 0件: | - | - | - |
322 |
Belzutifan
| - | 0件: | - | - | - |
323 |
Batoclimab
| - | 0件: | - | - | - |
324 |
Bergamot oil
| - | 0件: | - | - | - |
325 |
Brensocatib
| 1件: Brensocatib Brensocatib | 1件: Brensocatib Brensocatib; | 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
326 |
Balixafortide
| - | 0件: | - | - | - |